What US 21 CFR Part 600: Biological Products: General requires
US 21 CFR Part 600 sets out general requirements for the regulation of biological products including establishment standards, inspection authority of FDA, reporting of adverse experiences and biological product deviations, and…
This is a preview. The full record adds the complete summary, 8 workflow steps, 16 schema fields and 5 primary citations. Start a free trial or see pricing.
Pillar: Pharmaceuticals & Life Sciences · Authority: US FDA CBER · Version: 1.0.0 · Last updated:
Primary source: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-F/part-600
SHA-256 integrity: 9ba709e445bbec8998c2fa0d0ea245951c0121be67c5c13983e4648009fdd701
Primary Citations — 5 traced to source
- US 21 CFR Biological Products General
- US 21 CFR § 600.14 Reporting of biological product deviations
+ 3 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/us-21-cfr-part-600-biological-products-general.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/us-21-cfr-part-600-biological-products-general.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/us-21-cfr-part-600-biological-products-general
- Back to registry: Browse all 10,102 compliance nodes